A27 – Sector Peak Body Forum

This session will provide commentary from the key sector peak bodies on the future of the sector. Peak bodies play an important role in advocating for Pharma, Biotech and MedTech companies to government in relation to reimbursement and policies that influence access to novel drugs and devices.  How does Australia position itself in this global market and how should MTP associations manage the dichotomy between the needs of Australians to access new medications and the government’s position on funding R&D?  What needs to happen to ensure stability in sustainable healthcare in Australia?